CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors
Clinical trial NCT06503094 · UNKNOWN
Trial details
- NCT number
- NCT06503094
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-14
- Primary completion
- 2025-12-18
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.